Jason I. Herschkowitz
Jason I. Herschkowitz
Verified email at albany.edu
Title
Cited by
Cited by
Year
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
A Prat, JS Parker, O Karginova, C Fan, C Livasy, JI Herschkowitz, X He, ...
Breast cancer research 12 (5), 1-18, 2010
21192010
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
JI Herschkowitz, K Simin, VJ Weigman, I Mikaelian, J Usary, Z Hu, ...
Genome biology 8 (5), 1-17, 2007
13582007
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ...
Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009
13222009
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
JH Taube, JI Herschkowitz, K Komurov, AY Zhou, S Gupta, J Yang, ...
Proceedings of the National Academy of Sciences 107 (35), 15449-15454, 2010
9582010
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
KL Meerbrey, G Hu, JD Kessler, K Roarty, MZ Li, JE Fang, JI Herschkowitz, ...
Proceedings of the National Academy of Sciences 108 (9), 3665-3670, 2011
4862011
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
JI Herschkowitz, X He, C Fan, CM Perou
Breast Cancer Research 10 (5), 1-13, 2008
2382008
FOXC2 expression links epithelial–mesenchymal transition and stem cell properties in breast cancer
BG Hollier, AA Tinnirello, SJ Werden, KW Evans, JH Taube, TR Sarkar, ...
Cancer research 73 (6), 1981-1992, 2013
2322013
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ...
Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012
2132012
Characterization of mammary tumors from Brg1 heterozygous mice
SJ Bultman, JI Herschkowitz, V Godfrey, TC Gebuhr, M Yaniv, CM Perou, ...
Oncogene 27 (4), 460-468, 2008
1602008
Gene expression patterns associated with p53 status in breast cancer
MA Troester, JI Herschkowitz, DS Oh, X He, KA Hoadley, CS Barbier, ...
BMC cancer 6 (1), 1-13, 2006
1572006
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
AD Pfefferle, JI Herschkowitz, J Usary, JC Harrell, BT Spike, JR Adams, ...
Genome biology 14 (11), 1-16, 2013
1352013
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status
Z Jiang, T Deng, R Jones, H Li, JI Herschkowitz, JC Liu, VJ Weigman, ...
The Journal of clinical investigation 120 (9), 3296-3309, 2010
1302010
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex
Z Li, CE Tognon, FJ Godinho, L Yasaitis, H Hock, JI Herschkowitz, ...
Cancer cell 12 (6), 542-558, 2007
1282007
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
JH Taube, GG Malouf, E Lu, N Sphyris, V Vijay, PP Ramachandran, ...
Scientific reports 3 (1), 1-10, 2013
1142013
RB1 and p53 at the crossroad of EMT and triple-negative breast cancer
Z Jiang, R Jones, JC Liu, T Deng, T Robinson, PED Chung, S Wang, ...
Cell cycle 10 (10), 1563-1570, 2011
1012011
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
T Welte, IS Kim, L Tian, X Gao, H Wang, J Li, XB Holdman, ...
Nature cell biology 18 (6), 632-644, 2016
972016
c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer
R Nair, DL Roden, WS Teo, A McFarland, S Junankar, S Ye, A Nguyen, ...
Oncogene 33 (30), 3992-4002, 2014
882014
The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer
SB Greene, JI Herschkowitz, JM Rosen
RNA biology 7 (3), 300-304, 2010
882010
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer
JF Knight, R Lesurf, H Zhao, D Pinnaduwage, RR Davis, SMI Saleh, ...
Proceedings of the National Academy of Sciences 110 (14), E1301-E1310, 2013
732013
Predicting drug responsiveness in human cancers using genetically engineered mice
J Usary, W Zhao, D Darr, PJ Roberts, M Liu, L Balletta, O Karginova, ...
Clinical Cancer Research 19 (17), 4889-4899, 2013
682013
The system can't perform the operation now. Try again later.
Articles 1–20